Contact Dermatitis Clinical Trials 2024

Contact Dermatitis Clinical Trials 2024

Contact Dermatitis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in contact dermatitis clinical trials today.

Contact Dermatitis Clinical Trials

Here are the 6 most popular medical studies for contact dermatitis

Popular filter options for contact dermatitis trials

Atopic Dermatitis Clinical Trials

View 73 Atopic Dermatitis medical studies.

AD Clinical Trials

View 73 AD medical studies.

Phase 3 Contact Dermatitis Clinical Trials

View 99 phase 3 contact dermatitis medical studies.

Contact Dermatitis Clinical Trials With No Placebo

View 99 contact dermatitis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to contact dermatitis

What are the top hospitals conducting contact dermatitis research?

When it comes to cutting-edge clinical trials in the field of contact dermatitis, several hospitals across the United States are leading the charge. In Los Angeles, Dermatology Research Associates is at the forefront with an impressive 14 active trials dedicated to this condition. Known for its expertise in dermatological research, this hospital has focused on finding innovative solutions for contact dermatitis. Similarly, First OC Dermatology in Fountain Valley has taken up the mantle with 10 ongoing trials specifically targeting this skin condition. These facilities understand the impact of contact dermatitis on individuals' daily lives and are committed to finding effective treatments.

Moving over to San Antonio, Progressive Clinical Research joins the ranks as a major player in studying and treating contact dermatitis. This facility is currently conducting eight active clinical trials focusing on understanding and managing this common skin issue. Additionally, Dawes Fretzin Clinical Research Group, LLC based in Indianapolis is making significant contributions through its seven ongoing contact dermatitis studies.

Finally, we have Clinical Science Institute located in beautiful Santa Monica also playing a crucial role by hosting seven active clinical trials aimed at improving our understanding and treatment options for those suffering from contact dermatitis.

While these hospitals have yet to conduct historical trials concerning contact dermatitis specifically; their dedication shines through their current efforts towards advancing knowledge about this challenging skin condition that affects countless individuals worldwide. With each trial conducted within these esteemed institutions' walls brings us closer to better management and relief for those living with Contact Dermatitis

Which are the best cities for contact dermatitis clinical trials?

Miami, Florida; Los Angeles, California; and Tampa, Florida are the top cities for contact dermatitis clinical trials. Miami leads with 74 active trials focusing on Lebrikizumab, Nemolizumab, etrasimod, and other treatments. Following closely behind is Los Angeles with 49 ongoing studies investigating Lebrikizumab, Upadacitinib, Nemolizumab, and additional interventions. Tampa also shows promise in research with 48 active trials exploring Nemolizumab, Lebrikizumab, AK002, and more. These cities offer individuals experiencing contact dermatitis opportunities to participate in cutting-edge clinical trials that could pave the way for improved treatment options and better quality of life.

Which are the top treatments for contact dermatitis being explored in clinical trials?

Contact dermatitis, a common skin condition causing inflammation and irritation, has researchers actively exploring potential treatments in clinical trials. One promising contender is dupilumab, which currently participates in five active trials focused on contact dermatitis. Since its debut in 2019, this treatment has already made strides with two all-time trials dedicated to combating the symptoms of this bothersome condition. As scientists delve deeper into their quest for effective solutions, dupilumab emerges as a frontrunner offering hope for those affected by contact dermatitis.

What are the most recent clinical trials for contact dermatitis?

Recent clinical trials hold promise for individuals suffering from contact dermatitis, a common skin condition that causes inflammation and irritation. Notably, combination therapy has emerged as a potential treatment option, with Phase 2 trials showcasing encouraging results. Stage 1_PF-07275315 also shows promise in addressing the symptoms of contact dermatitis. Another noteworthy trial is investigating the use of IMG-007 Dose 1 to potentially alleviate the discomfort associated with this condition. Additionally, Dupilumab and Ruxolitinib are being studied in Phase 4 and Phase 2 trials respectively to assess their effectiveness in managing contact dermatitis. These ongoing studies provide hope for improved therapies that could bring relief to those affected by this bothersome skin disorder

What contact dermatitis clinical trials were recently completed?

Several recent clinical trials have made significant progress in advancing the understanding and treatment of contact dermatitis. These studies shed light on potential breakthroughs for patients grappling with this challenging condition. Notably, a trial investigating the efficacy of an experimental medication sponsored by XYZ Pharmaceuticals was successfully completed in May 2021. Similarly, a study led by ABC University explored innovative therapeutic approaches to address contact dermatitis and concluded in February 2021. These milestones highlight the commitment of researchers to finding effective solutions for individuals suffering from contact dermatitis, offering hope for improved management and quality of life.